TI
tru Independence Portfolio holdings
AUM
$346M
This Quarter Return
-20.27%
1 Year Return
+13.72%
3 Year Return
+42.26%
5 Year Return
+64.25%
10 Year Return
–
AUM
$613K
AUM Growth
+$613K
(-100%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-26,497.69%
Top 10 Holdings %
Top 10 Hldgs %
43.1%
Holding
962
New
3
Increased
45
Reduced
74
Closed
211
Top Buys
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$49.3K |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
$29.5K |
| 3 |
Schwab International Equity ETF
SCHF
|
$19.5K |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$16.2K |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$15.1K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$49.3M |
| 2 |
iShares Biotechnology ETF
IBB
|
$8.61M |
| 3 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
$7.07M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$7.06M |
| 5 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
$6.75M |
Sector Composition
| 1 | Technology | 10.3% |
| 2 | Healthcare | 9.04% |
| 3 | Financials | 7.21% |
| 4 | Consumer Staples | 6.76% |
| 5 | Consumer Discretionary | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Columbia Emerging Markets Consumer ETF
ECON
$218M
| $74K | 12.06% | 195 | – | – |
|
|
BMY.RT
2
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $49.3K | 8.03% | 1,081,698 +1,081,643 | +1,966,624% | +$49.3K |
|
|
3
iShares Core S&P US Value ETF
IUSV
$22B
| $29.8K | 4.85% | 329,917 +327,380 | +12,904% | +$29.5K |
|
|
4
Schwab International Equity ETF
SCHF
$50.3B
| $24.1K | 3.93% | 576,704 +465,960 | +421% | +$19.5K |
|
|
5
SPDR S&P Biotech ETF
XBI
$5.07B
| $21.5K | 3.5% | 378,743 +265,559 | +235% | +$15.1K |
|
|
6
Energy Select Sector SPDR Fund
XLE
$27.6B
| $21K | 3.42% | 618,348 +477,447 | +339% | +$16.2K |
|
7
Cognizant
CTSH
$35.3B
| $16K | 2.6% | 225 -600 | -73% | -$42.6K |
|
8
Gilead Sciences
GILD
$140B
| $10.1K | 1.65% | 135,656 | – | – |
|
9
Microsoft
MSFT
$3.77T
| $10.1K | 1.65% | 64,271 -26,180 | -29% | -$4.13K |
|
10
Coca-Cola
KO
$297B
| $8.54K | 1.39% | 6,116 -2,423 | -28% | -$3.38K |
|
11
Citigroup
C
$178B
| $8.2K | 1.34% | 3,247 -4,951 | -60% | -$12.5K |
|
12
Apple
AAPL
$3.45T
| $7.7K | 1.26% | 30,284 -16,675 | -36% | -$4.24K |
|
13
CVS Health
CVS
$92.8B
| $7.29K | 1.19% | 122,858 -4,105 | -3% | -$244 |
|
14
Pfizer
PFE
$141B
| $6.99K | 1.14% | 214,211 -119,975 | -36% | -$3.92K |
|
15
Intel
INTC
$107B
| $6.58K | 1.07% | 121,513 -83,102 | -41% | -$4.5K |
|
16
Vanguard Industrials ETF
VIS
$6.14B
| $5.91K | 0.96% | 47,292 +37,534 | +385% | +$4.69K |
|
17
AT&T
T
$209B
| $5.69K | 0.93% | 195,245 -182,760 | -48% | -$5.33K |
|
18
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.05B
| $5.63K | 0.92% | 98,614 +98,267 | +28,319% | +$5.61K |
|
19
JPMorgan Chase
JPM
$829B
| $5.57K | 0.91% | 61,844 -45,088 | -42% | -$4.06K |
|
20
Vanguard Short-Term Bond ETF
BSV
$38.5B
| $5.44K | 0.89% | 63,728 +28,550 | +81% | +$2.44K |
|
21
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.33B
| $5.42K | 0.88% | 51,222 +6 | +0% | +$1 |
|
22
Bank of America
BAC
$376B
| $5.32K | 0.87% | 250,474 -15,225 | -6% | -$323 |
|
23
Merck
MRK
$210B
| $4.9K | 0.8% | 33,718 -51,600 | -60% | -$7.5K |
|
24
General Mills
GIS
$26.4B
| $4.74K | 0.77% | 89,745 -84,225 | -48% | -$4.45K |
|
25
Kroger
KR
$44.9B
| $4.71K | 0.77% | 156,358 -256,430 | -62% | -$7.72K |
|